News | March 28, 2022
Tata Capital Healthcare Fund II raises Rs 955 crore
The fund will take equity positions in India-focused healthcare and life sciences-related companies
The fund will take equity positions in India-focused healthcare and life sciences-related companies
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The CO2 Optimization module is one of the four modules (Product Costing, BoM Management, CO2 Optimization, Supplier Strategy) within the entire NDC Simulation Suite
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
In the interim, Deepak Khanna will lead Human Health International.
Key takeaways of Q3FY22 quarter & conference call highlights
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
The antimicrobial resistance alliance recently released its third Progress Report, reflecting on collective achievements from the life sciences industry
Sun Pharma’s Q3FY22 operational performance was in line with I-direct estimates with sustained momentum and good growth across businesses
Subscribe To Our Newsletter & Stay Updated
